Oncopharmpod
Cycling thru the CDK Inhibitors
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:18:28
- More information
Informações:
Synopsis
Abemaciclib's up-front approval provides an opportunity to review all 3 currently FDA-approved CDK 4/6 inhibitors. Dosing, drug interaction, and indication differences are discussed.
